These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17890948)

  • 21. Evaluation of the sensitivity of an in vitro high frequency ultrasound device to monitor the coagulation process: study of the effects of heparin treatment in a murine model.
    Callé R; Rochefort GY; Desbuards N; Plag C; Antier D; Ossant F
    Ultrasound Med Biol; 2010 Feb; 36(2):295-305. PubMed ID: 20045589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of antithrombin-dependent factor Xa inhibitors by prothrombin-induced clotting time.
    Harenberg J; Giese C; Hagedorn A; Traeger I; Fenyvesi T
    Semin Thromb Hemost; 2007 Jul; 33(5):503-7. PubMed ID: 17629847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the SonoClot Analyzer for the measurement of platelet function in whole blood.
    LaForce WR; Brudno DS; Kanto WP; Karp WB
    Ann Clin Lab Sci; 1992; 22(1):30-3. PubMed ID: 1739271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sonoclot analysis in cardiac surgery in dialysis-dependent patients.
    Shibata T; Sasaki Y; Hattori K; Hirai H; Hosono M; Fujii H; Suehiro S
    Ann Thorac Surg; 2004 Jan; 77(1):220-5. PubMed ID: 14726065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of the inhibitory effect of fondaparinux on thrombin generation by rFVIIa, aPCC and PCC.
    Desmurs-Clavel H; Huchon C; Chatard B; Negrier C; Dargaud Y
    Thromb Res; 2009 Mar; 123(5):796-8. PubMed ID: 18771795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
    Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
    Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring direct FXa-inhibitors and fondaparinux by Prothrombinase-induced Clotting Time (PiCT): relation to FXa-activity and influence of assay modifications.
    Harder S; Parisius J; Picard-Willems B
    Thromb Res; 2008; 123(2):396-403. PubMed ID: 18571698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of heparin anticoagulation by Sonoclot Analyzer in arterial reconstruction surgery.
    Lee B; Al-Waili N; Butler G; Salom K
    Technol Health Care; 2011; 19(2):109-14. PubMed ID: 21422535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetoelastic transducers for monitoring coagulation, clot inhibition, and fibrinolysis.
    Puckett LG; Lewis JK; Urbas A; Cui X; Gao D; Bachas LG
    Biosens Bioelectron; 2005 Mar; 20(9):1737-43. PubMed ID: 15681188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
    Haas T; Fries D; Velik-Salchner C; Reif C; Klingler A; Innerhofer P
    Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Sonoclot hemostasis analysis after cardiopulmonary bypass on postoperative hemorrhage in cardiac surgery.
    Yamada T; Katori N; Tanaka KA; Takeda J
    J Anesth; 2007; 21(2):148-52. PubMed ID: 17458642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing.
    Gosselin RC; King JH; Janatpur KA; Dager WH; Larkin EC; Owings JT
    Arch Pathol Lab Med; 2004 Oct; 128(10):1142-5. PubMed ID: 15387708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the hemostatic clot formation of newborns by Sonoclot coagulation analyzer.
    Yang YC; Tsai SK; Ng KO; Keung LK; Hseu SS; Lee TY
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Aug; 56(2):115-9. PubMed ID: 7553418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficiency of anti-activated factor X and anti-activated factor II anticoagulants.
    Stief TW
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):265-9. PubMed ID: 17413764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prothrombinase-induced clotting time assay for determination of the anticoagulant effects of unfractionated and low-molecular-weight heparins, fondaparinux, and thrombin inhibitors.
    Calatzis A; Peetz D; Haas S; Spannagl M; Rudin K; Wilmer M
    Am J Clin Pathol; 2008 Sep; 130(3):446-54. PubMed ID: 18701419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
    Dempfle CE; Kälsch T; Elmas E; Suvajac N; Lücke T; Münch E; Borggrefe M
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):765-70. PubMed ID: 19002042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pravastatin potentiates the anticoagulant effects of low molecular weight heparin.
    Zimmer JE; Spillert CR; Puppala S; Zamecki K; Bhatt BA; Arora RR
    Thromb Res; 2004; 113(6):407-10. PubMed ID: 15226096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viscoelastic measurement of clot formation: a new test of platelet function.
    Saleem A; Blifeld C; Saleh SA; Yawn DH; Mace ML; Schwartz M; Crawford ES
    Ann Clin Lab Sci; 1983; 13(2):115-24. PubMed ID: 6602584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sonoclot analysis in coronary artery surgery: a comparison between patients with unstable coronary artery disease treated with enoxaparin before surgery and patients with stable coronary artery disease not treated with enoxaparin.
    Pleym H; Wahba A; Bjella L; Stenseth R
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):670-4. PubMed ID: 18922421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux.
    Lisman T; Bijsterveld NR; Adelmeijer J; Meijers JC; Levi M; Nieuwenhuis HK; De Groot PG
    J Thromb Haemost; 2003 Nov; 1(11):2368-73. PubMed ID: 14629471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.